Spyre Therapeutics, Inc. (NASDAQ:SYRE – Get Free Report) CFO Scott Burrows sold 7,500 shares of the company’s stock in a transaction dated Monday, August 3rd. The shares were sold at an average price of $95.57, for a total transaction of $716,775.00. Following the completion of the transaction, the chief financial officer owned 97,994 shares in […]